Venus concept announces $1.2 million registered direct offering priced at-the-market under nasdaq rules

Toronto, feb. 23, 2024 (globe newswire) -- venus concept inc. (“venus concept” or the “company”) (nasdaq: vero), a global medical aesthetic technology leader, today announced that it has entered into definitive agreements for the purchase and sale of 817,748 shares of common stock at a purchase price of $1.465 per share in a registered direct offering priced at-the-market under nasdaq rules. in a concurrent private placement, the company will issue unregistered warrants to purchase up to 817,748 shares of common stock at an exercise price of $1.34 per share that will be immediately exercisable upon issuance and will expire five years following the date of issuance. the closing of the offering is expected to occur on or about february 27, 2024, subject to the satisfaction of customary closing conditions.
VERO Ratings Summary
VERO Quant Ranking